Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Debt to Equity (2016 - 2026)

Apyx Medical filings provide 14 years of Debt to Equity readings, the most recent being $2.4 for Q4 2025.

  • On a quarterly basis, Debt to Equity rose 1.37% to $2.4 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.4, a 1.37% increase, with the full-year FY2025 number at $2.4, up 1.37% from a year prior.
  • Debt to Equity hit $2.4 in Q4 2025 for Apyx Medical, down from $5.69 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $5.69 in Q3 2025 to a low of $0.24 in Q2 2023.
  • Median Debt to Equity over the past 3 years was $2.31 (2024), compared with a mean of $2.26.
  • Biggest five-year swings in Debt to Equity: soared 1027.14% in 2024 and later rose 1.37% in 2025.
  • Apyx Medical's Debt to Equity stood at $1.23 in 2023, then skyrocketed by 91.81% to $2.36 in 2024, then grew by 1.37% to $2.4 in 2025.
  • The last three reported values for Debt to Equity were $2.4 (Q4 2025), $5.69 (Q3 2025), and $4.61 (Q2 2025) per Business Quant data.